How Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD
Update: 2024-12-03
Description
Arvinas is a biotech company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. In this podcast episode, Dr. Randy Teel discusses the company's PROTAC protein degrader technology platform and its pipeline of clinical-stage assets, with a focus on vepdegestrant, the company's lead asset that is being co-developed together with partner Pfizer, for the treatment of women with early and locally advanced or metastatic ER+/HER2- breast cancer.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
